ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

DXR Daxor Corporation

9.5527
-0.121 (-1.25%)
2024年5月11日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Daxor Corporation DXR NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.121 -1.25% 9.5527 05:10:38
始値 安値 高値 終値 前日終値
9.67 9.49 9.67 9.5527 9.6737
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1621:00GLOBENew Studies Prove the Clinical Benefits of Daxor’s Blood..
2024/4/1521:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
2024/4/1021:00GLOBEDaxor Corporation Announces New Hospital Account at Leading..
2024/4/0121:00GLOBEDaxor Corporation to Exhibit at the American College of..
2024/3/2521:00GLOBEDaxor Corporation Acquires Volumex® and Megatope® From Its..
2024/3/2221:00GLOBEDaxor Corporation to Hold Investor Call Discussing Fiscal..
2024/3/1903:18GLOBEDaxor Corporation CEO and President Michael Feldschuh..
2024/3/1121:00GLOBEDaxor Announces Sales to Three New Hospitals Furthering..
2024/3/0903:49EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
2024/3/0822:00GLOBEMulti-Center Study Presented by Duke at Heart Failure..
2024/3/0706:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:28EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
2024/3/0106:15EDGAR2Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of..
2024/2/2622:00GLOBEDaxor Corporation to Exhibit at the Technology and Heart..
2024/2/1222:00GLOBEDaxor Corporation Starts 2024 with Ongoing Growth in New..
2024/2/0722:00GLOBEDaxor Corporation Closes Q4 2023 with Growth in New Sales to..
2024/1/2922:00GLOBEDaxor Corporation to Exhibit at the Society of Nuclear..
2024/1/1622:00GLOBEDaxor Corporation to Exhibit at the Society for Critical..
2024/1/0922:00GLOBEDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME..
2024/1/0222:52EDGAR2Form 8-K - Current report
2024/1/0222:30GLOBEDaxor Corporation Submits Dual 510(k)/CLIA-waiver..
2023/12/0705:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0211:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0210:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2720:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2503:53EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
2023/11/2501:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1322:00GLOBENew Randomized Controlled Trial Demonstrates the Efficacy of..
2023/11/1320:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0922:00GLOBEDaxor Corporation Awarded New Patent for Remote Monitoring..
2023/11/0307:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2806:27EDGAR2Form 8-K - Current report
2023/10/1701:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1321:00GLOBEExpert Panelists Advocate Use of Daxor’s Technology to..
2023/10/1121:00GLOBENew Data from Banner University Medicine Demonstrating..
2023/10/0421:00GLOBEDaxor Corporation Awarded Support from the National..
2023/9/2721:00GLOBEDaxor Corporation to Exhibit at the Heart Failure Society of..
2023/9/2622:14EDGAR2Form 40-17G - Fidelity Bond [Rule 17G-1(g)]
2023/9/2621:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
2023/9/2105:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1201:00GLOBEDaxor Corporation Awarded $305K Grant from the National..
2023/9/0722:15GLOBEDaxor Corporation to Present at the H.C. Wainwright 25th..
2023/8/2905:15GLOBEDaxor Corporation CEO and President Michael Feldschuh..
2023/8/2905:05GLOBEDaxor Corporation Reports a 20.64 Percent Increase in..
2023/8/2905:01EDGAR2Form N-CSRS - Certified Shareholder Report, Semi-Annual
2023/8/1520:14EDGAR2Form N-PX - Annual Report of proxy voting record of..
2023/8/1021:00GLOBEJACC-HF Reports Successful Heart Failure Trial With Daxor..
2023/7/1405:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1405:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1405:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄